REUTERS Watson Pharmaceuticals to buy Andrx for $1.9 bln
CHICAGO, March 13 (Reuters) - Watson Pharmaceuticals Inc. <WPI.N> has signed a definitive agreement to buy fellow generic drug maker Andrx Corp. <ADRX.O> for $1.9 billion, the companies said on Monday.
Watson will acquire all outstanding common stock of Andrx for $25 per share, they said.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.